When it comes to delivering trials on time, every process matters. And, every timeline matters. In Study Startup, that means ensuring the right standards and processes are in place to launch a study. However, what happens when a global pandemic causes the start-up process, to slow down?
At PSI CRO, 75% of trials completed enrollment on time or ahead of schedule in 2020. In the middle of a global pandemic, our teams worked tirelessly to adapt, overcome, and deliver. In this webinar, dive in to one of the key parts of the clinical trial process that ensures trial timelines: Study Startup
Join Diana Fowler, Head of Study Startup, and Gopi Sadashivaiah, Director Study Startup, as they discuss the secrets of success to on-time study start up globally, even during a global pandemic.
Key Learning Objectives
- What is study startup, and how does it contribute to the overall clinical trial timeline?
- What are the key considerations sponsors should look for in a startup strategy?
- The secrets in the statistics: study startup during a pandemic (real-life examples and case studies of planned v. actual FPI)
Audience
- Geologist
- Geophysicist
- Reservoir Engineer
- Exploration Manager
- Asset Manager
